[MDGL] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
10-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -39.14%
YoY- -147.03%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -6,364 -8,445 -8,363 -8,347 -5,999 -7,749 -14,049 -41.04%
Tax 0 -276 100 0 0 142 -11,991 -
NP -6,364 -8,445 -8,363 -8,347 -5,999 -7,749 -14,049 -41.04%
Tax Rate - - - - - - - -
Total Cost 6,364 8,445 8,363 8,347 5,999 7,749 14,049 -41.04%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
EPS -0.45 -0.67 -0.68 -0.69 -0.50 -0.67 -1.59 -56.92%
EPS Diluted -0.45 -0.67 -0.68 -0.69 -0.50 -0.67 -1.59 -56.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.